Janux Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.About JANX
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
JANX Key Statistics
Stock Snapshot
With a market cap of 1.04B, Janux Therapeutics(JANX) trades at $16.96. The stock has a price-to-earnings ratio of -9.89.
On 2026-08-18, Janux Therapeutics(JANX) stock moved within a range of $16.05 to $16.99. With shares now at $16.96, the stock is trading +5.7% above its intraday low and -0.2% below the session's peak.
Trading volume for Janux Therapeutics(JANX) stock has reached 567.24K, versus its average volume of 614.16K.
Over the past 52 weeks, Janux Therapeutics(JANX) stock has traded between a high of $35.34 and a low of $12.12.
Over the past 52 weeks, Janux Therapeutics(JANX) stock has traded between a high of $35.34 and a low of $12.12.
Analyst ratings
79%
of 19 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.